from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. The Company's financial results for the quarter ended September 30, 2013 may not necessarily be indicative of future results. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2012, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.
For more information about PBI and this press release, please click on the following website link:
Please visit us on: Facebook, LinkedIn, and Twitter.
PRESSURE BIOSCIENCES, INC. AND SUBSIDIARYCONDENSED CONSOLIDATED BALANCE SHEETSSeptember 30,December 31,ASSETS20132012(Unaudited)(Audited)CURRENT ASSETSCash and cash equivalents
200,914216,265Inventories, net of $50,000 reserve at September 30, 2
Page: 1 2 3 4 5 6 7 Related biology technology :1
|SOURCE Pressure BioSciences, Inc.|
Copyright©2012 PR Newswire.
All rights reserved
. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update2
. Blood Pressure Monitoring Testing Market is Expected to Reach USD 3.7 Billion Globally in 2019: Transparency Market Research3
. Hazardous, High-Pressure and Explosive Conditions Are No Match for Swiss Jewel Sapphire Windows4
. Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update5
. China Medical Flat Panel Detector Market & Pressure Injector 2013 Research Reports Now Available at ReportsnReports.com6
. Using pressure to swell pores, not crush them7
. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal8
. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update9
. High pressure gold nanocrystal structure revealed10
. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)11
. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research